Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Uber Technologies Inc (UBER) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Uber Technologies IncTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Uber Technologies Inc vs Vir Biotechnology Inc. Common Stock — how do they compare? Uber Technologies Inc trades at $68.8 (market cap $145.68B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.76B). The key difference: Uber Technologies Inc is far larger — about 82.8× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Uber Technologies Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Uber Technologies Inc for 88 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

UBERVIR
Market Cap
$145.68B$1.76B
Volume
12,849,2632,764,948
Sector
TechnologyHealth
52-Week High
$99.72$11.78
52-Week Low
$65.94$5.12
Typical Hold Time
88 Days0 Days
Enterprise Value
$155.02B$1.32B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Uber Technologies Inc

Uber Technologies (UBER) trades at $71.32, down 0.25% on the day, with strong fundamental momentum as revenue grew to $52.02 billion in 2025 and net income reached $10.05 billion. The stock shows a bullish technical signal despite mixed moving averages, with key support at $69-70. Recent expansion of the Costco delivery partnership to 47 states and CEO share purchases of $10 million signal confidence in growth prospects.

Uber presents a compelling investment case with 82.5% analyst buy ratings and a $104.72 consensus target, representing 47% upside. Risks include projected negative cash flow in 2026 and competitive pressures in autonomous vehicles. The company's transition to sustained profitability and strategic partnerships support long-term growth potential despite near-term execution challenges.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

UBER
17% Buy83% Sell
Avg holding period · 88 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Uber Technologies Inc

Uber Technologies is a technology provider that matches riders with drivers, hungry people with restaurants and food delivery service providers, and shippers with carriers. The firm's on-demand technology platform could eventually be used for additional products and services, such as autonomous vehicles, delivery via drones, and Uber Elevate, which, as the firm refers to it, provides aerial ride-sharing. Uber Technologies is headquartered in San Francisco and operates in over 63 countries with over 110 million users that order rides or foods at least once a month. Approximately 76% of its gross revenue comes from ride-sharing and 22% from food delivery.

Read more on UBER →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →